[1]莫晓嫦*,王建,冯兰青,等.甲状腺过氧化物酶抗体水平对促甲状腺激素正常的多囊卵巢综合征不孕患者促排卵效果及妊娠成功率的预测价值[J].中国计划生育和妇产科,2019,(7):45-48.
　MO Xiao-chang*,WANG Jian,FENG Lan-qing,et al.Predicting value of TPOAb level in ovulation induction and pregnancy success rate in patients with PCOS infertility with normal TSH[J].Chinese Journal of Family Planning & Gynecotokology,2019,(7):45-48.
点击复制

甲状腺过氧化物酶抗体水平对促甲状腺激素正常的多囊卵巢综合征不孕患者促排卵效果及妊娠成功率的预测价值
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年7期
页码:
45-48
栏目:
论著与临床
出版日期:
2019-06-25

文章信息/Info

Title:
Predicting value of TPOAb level in ovulation induction and pregnancy success rate in patients with PCOS infertility with normal TSH
作者:
莫晓嫦*; 王建; 冯兰青; 罗恩斯
东莞东华医院生殖医学中心
Author(s):
MO Xiao-chang*;  WANG Jian; FENG Lan-qing;  LUO En-si
Department of Reproductive Medicine Center,Dongguan Donghua Hospital， Dongguan Guangdong 523110,P.R.China
关键词:
甲状腺过氧化物酶抗体; 多囊卵巢综合征; 不孕; 促排卵; 妊娠成功率; 预测
Keywords:
thyroid peroxidase antibody; polycystic ovary syndrome; infertility; ovulation induction;  pregnancy success rate;  prediction
分类号:
R 71175
摘要:
目的探讨甲状腺过氧化物酶抗体（thyroid peroxidase antibody，TPOAb）水平对促甲状腺激素（thyroid stimulating hormone，TSH）正常的多囊卵巢综合征（polycystic ovary syndrome，PCOS）不孕患者促排卵效果及妊娠成功率的预测价值。方法回顾性分析2016年6月至2017年6月东莞东华医院生殖医学中心收治的65例TSH正常的PCOS不孕患者的临床资料，将其纳入研究组，另选取同期医院体检中心收治的40例健康女性纳入对照组，对比研究组和对照组TPOAb水平；研究组常规促排卵治疗，根据阴道超声检查是否出现排卵征象将其分别纳入排卵组和未排卵组，对比两组TPOAb水平；根据是否临床妊娠，将其分别纳入成功组和失败组，对比两组TPOAb水平；通过绘制受试者工作曲线（subject working curve，ROC），分析TPOAb水平对促排卵及妊娠成功的影响。结果研究组TPOAb水平［（11025±2037）IU/mL］明显高于对照组［（4251±817）IU/mL］，差异有统计学意义（P＜005）；65例TSH正常的PCOS不孕患者排卵率为7846 %（51/65），未排卵组TPOAb水平［（17775±2183）IU/mL］明显高于排卵组［（9172±1064）IU/mL］，差异有统计学意义（P＜005）；51例排卵患者中临床妊娠成功率为2941 %（15/51），失败组TPOAb水平［（10387±1295）IU/mL］明显高于成功组［（6256±770）IU/mL］，差异有统计学意义（P＜005）；TPOAb预测TSH正常的PCOS不孕患者促排卵及妊娠成功的最佳截断点分别为9270 IU/mL、6526 IU/mL，TPOAb预测TSH正常的PCOS不孕患者排卵的灵敏度、准确度及曲线下面积高于预测妊娠成功组，特异度低于预测妊娠成功组。结论TPOAb水平对TSH正常的PCOS不孕患者促排卵及妊娠成功具有一定预测价值，且对促排卵预测价值较高。
Abstract:
Objective To investigate the predictive value of thyroid peroxidase antibody (TPOAb) level in ovulation induction and pregnancy success rate in infertility patients with polycystic ovary syndrome (PCOS) infertility with normal thyroid stimulating hormone(TSH).MethodsRetrospective analysis of 65 patients with PCOS infertility with normal TSH who were admitted to the Dongguan Donghua Hospital from June 2016 to June 2017 was included in the study group. 40 healthy women who were admitted to the hospital physical examination center were included in the control group. The TPOAb levels of the study group and the control group were compared. The study group routinely promoted ovulation treatment, according to vaginal ultrasound examination whether ovulation signs were included in the ovulation group and the non-ovulation group, respectively, the two groups of TPOAb levels were compared. Follow-up statistics were included in the clinical pregnancy, and they were included in the successful group and the failed group, respectively, and the levels of TPOAb in the two groups were compared. The predictive value of TPOAb levels for ovulation induction and pregnancy success was analyzed by plotting subject working curve (ROC). ResultsThe level of TPOAb in the study group was significantly higher than that in the control group (P<005). The ovulation rate of 65 patients with PCOS infertility with mormal TSH was 7846 % (51/65), and the level of TPOAb in the non-ovulation group was significantly higher than that in the ovulation group (P<005). The clinical pregnancy success rate was 2941 % (15/51) in 51 patients with ovulation, and the TPOAb level in the failure group was significantly higher than that in the successful group (P<005). The best cut-off points for TPOAb predicting ovulation and pregnancy success in patients with PCOS infertility with normal TSH are 9270 IU/mL and 6526 IU/mL, respectively. TPOAb predicts the sensitivity, accuracy and AUC of ovulation in patients with PCOS infertility with nomal TSH, which is higher than the predicted pregnancy success, and the specificity is lower than the predicted pregnancy success. ConclusionThe level of TPOAb has a certain predictive value for ovulation induction and pregnancy success in patients with PCOS infertility with normal TSH, and it has a higher predictive value for ovulation induction.

参考文献/References:

［1］LI YM. Acupuncture for Infertility in Polycystic Ovary Syndrome ［J］. JAMA, 2017, 318 (15):1501-1502. ［2］高婷婷，李博，陈书强，等．陕西省育龄期女性多囊卵巢综合征流行病学特点分析 ［J］．中国妇幼健康研究，2016，27（5）：584-586． ［3］曲仕浩，徐楗荧，黄晓清，等．广东省阳江地区初婚育龄夫妇不孕不育症流行病学调查［J］. 广东医学，2017，38 (10)：1586-1588． ［4］崔琳琳，陈子江．多囊卵巢综合征诊断标准和诊疗指南介绍 ［J］．国际生殖健康/计划生育杂志，2011，30（5）：405-408． ［5］林津，马炎辉，谢红斌，等．血清β-HCG、孕酮联合B超测定对早期异常妊娠诊断价值探讨 ［J］．中国妇幼保健，2008，23（36）：5170-5172． ［6］陈婷婷，傅萍，邢佳，等．多囊卵巢综合征发病机制的影响因子研究 ［J］．中国优生与遗传杂志，2016，24（11）：122-125． ［7］EEKAN G, TAYYAR AT, ACMAZ G, et al. Role ofosteocalcin, tumor necrosis factoralpha and adiponectin in polycystic ovarysyndrome patients with insulin resistance ［J］. Turk J Obstet Gynecol, 2017, 14 (2):89-93.. ［8］王钰，李小燕，宋民喜．不同表型多囊卵巢综合征患者甲状腺功能改变及临床意义 ［J］．陕西医学杂志，2016，45（10）：1303-1305． ［9］MENON M, RAMACHANDRAN V. Antithyroid peroxidase antibodies in women with polycystic ovary syndrome ［J］. J Obstet Gynaecol India, 2017, 67 (1):61-65. ［10］何可，程腊梅．免疫紊乱与多囊卵巢综合征 ［J］．中华生殖与避孕杂志，2017，37（12）：1028-1030． ［11］GONG P, SHI B, WANG J, et al. Association between Th1/Th2 immune imbalance and obesity in women with or without polycystic ovary syndrome ［J］. Gynecol Endocrinol, 2018, 34 (8):709-714. ［12］FESSLER DMT, NATTERSON-HOROWITZ B, AZZIZ R. Evolutionary determinants ofpolycystic ovary syndrome: part 2 ［J］. Fertil Steril, 2016, 106 (1):42-47. ［13］李凝旭，黄莺，涂艳，等．绝经后女性骨密度与雌激素水平、免疫细胞因子和骨代谢指标的相关性研究 ［J］．中国免疫学杂志，2017，33（8）：1201-1204． ［14］宁静，陈军，张宝莲．妊娠早期甲状腺过氧化物酶抗体和(或)甲状腺球蛋白抗体阳性与不良妊娠结局的关系 ［J］．解放军医学院学报，2017，38（1）：22-25． ［15］BENETTI-PINTO CL, PICCOLO VB, YELA DA, et al. Thyroid-stimulating Hormoneand Insulin Resistance: Their Association with Polycystic Ovary Syndrome without Overt Hypothyroidism ［J］. Rev Bras Ginecol Obstet, 2017, 39 (5):224-228.

相似文献/References:

[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
　JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(7):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
　REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(7):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
　GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(7):0.
[4]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
　LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[5]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
　LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[6]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
　LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(7):0.
[7]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[8]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[9]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[10]李尚为.多囊卵巢综合征的促排卵治疗[J].中国计划生育和妇产科,2014,(06):0.

备注/Memo

备注/Memo:
东莞市社会科技发展（一般）项目（项目编号：2018507150461218）
更新日期/Last Update: 2019-07-25